Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2013, Article ID 315479, 3 pages
http://dx.doi.org/10.1155/2013/315479
Case Report

Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib

1Division of Gastroenterology and Hepatology, Bronx Lebanon Hospital Center, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10457, USA
2Department of Medicine, Bronx Lebanon Hospital Center, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10457, USA
3Department of Pathology, Bronx Lebanon Hospital Center, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10457, USA

Received 5 February 2013; Accepted 21 May 2013

Academic Editor: Ingo W. Husstedt

Copyright © 2013 Suresh Kumar Nayudu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Castellsague, N. Riera-Guardia, B. Calingaert et al., “Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS Project),” Drug Safety, vol. 35, pp. 1127–1146, 2012. View at Google Scholar
  2. H. Tong, X. Li, C. L. Zhang et al., “Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with Hepatic VX2 allografts,” Journal of Digestive Diseases, vol. 14, no. 1, pp. 29–37, 2013. View at Publisher · View at Google Scholar
  3. H. Ozturk, A. Gezici, and H. Ozturk, “The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats,” Hepatology Research, vol. 34, no. 2, pp. 76–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Márquez-Rosado, M. C. Trejo-Solís, C. M. García-Cuéllar, and S. Villa-Treviño, “Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats,” Journal of Hepatology, vol. 43, no. 4, pp. 653–660, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Zuo, Z. Li, X. Zhou, Y. Ouyang, Z. Zhou, and L. Zeng, “Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice,” Ai Zheng, vol. 25, no. 4, pp. 414–420, 2006. View at Google Scholar · View at Scopus
  6. P. Chamouard, P. Walter, R. Baumann, and R. Poupon, “Prolonged cholestasis associated with short-term use of celecoxib,” Gastroenterologie Clinique et Biologique, vol. 29, no. 12, pp. 1286–1288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Carrillo-Jimenez and M. Nurnberger, “Celecoxib-induced acute pancreatitis and hepatitis: a case report,” Archives of Internal Medicine, vol. 160, no. 4, pp. 553–554, 2000. View at Google Scholar · View at Scopus
  8. R. P. Eckstein, J. F. Dowsett, and M. R. Lunzer, “Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy,” Pathology, vol. 25, no. 3, pp. 223–228, 1993. View at Google Scholar · View at Scopus
  9. J. S. Kim, Y. R. Jang, J. W. Lee et al., “A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage,” The Korean Journal of Hepatology, vol. 17, no. 3, pp. 229–232, 2011. View at Google Scholar · View at Scopus
  10. I. I. El Hajj, S. M. Malik, H. R. Alwakeel, O. S. Shaikh, E. Sasatomi, and H. M. Kandil, “Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation,” World Journal of Gastroenterology, vol. 15, no. 31, pp. 3937–3939, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. M. Xu, Y. Chen, J. Xu, and Q. Zhou, “Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase,” World Journal of Gastroenterology, vol. 18, pp. 5972–5978, 2012. View at Google Scholar
  12. H. Xie, L. Gao, N. Chai et al., “Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib,” Molecular Carcinogenesis, vol. 48, no. 1, pp. 56–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. M. E. Salcido-Neyoy, A. Sierra-Santoyo, O. Beltrán-Ramírez, J. R. Macías-Pérez, and S. Villa-Treviño, “Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer,” World Journal of Gastroenterology, vol. 15, no. 19, pp. 2345–2350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. V. Galan, S. C. Gordon, and A. L. Silverman, “Celecoxib-induced cholestatic hepatitis,” Annals of Internal Medicine, vol. 134, no. 3, article 254, 2001. View at Google Scholar · View at Scopus
  15. J. P. O'Beirne and S. R. Cairns, “Drug points: cholestatic hepatitis in association with celecoxib,” British Medical Journal, vol. 323, no. 7303, article 23, 2001. View at Google Scholar · View at Scopus
  16. A. Grieco, L. Miele, A. Giorgi, I. M. Civello, and G. Gasbarrini, “Acute cholestatic hepatitis associated with celecoxib,” Annals of Pharmacotherapy, vol. 36, no. 12, pp. 1887–1889, 2002. View at Google Scholar · View at Scopus
  17. C. Sgro, F. Clinard, K. Ouazir et al., “Incidence of drug-induced hepatic injuries: a French population-based study,” Hepatology, vol. 36, no. 2, pp. 451–455, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Green and S. Flamm, “AGA technical review on the evaluation of liver chemistry tests,” Gastroenterology, vol. 123, no. 4, pp. 1367–1384, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. G. R. Lichtensin, “American gastroenterological association medical position statement: evaluation of liver chemistry tests,” Gastroenterology, vol. 123, no. 4, pp. 1364–1366, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. Barritt IV, J. Lee, and P. H. Hayashi, “Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness,” Clinical Gastroenterology and Hepatology, vol. 8, no. 7, pp. 635–637, 2010. View at Publisher · View at Google Scholar · View at Scopus